Search found 188 matches
- Wed Jan 05, 2005 1:13 am
- Forum: Rebif
- Topic: New Study Rebif to Copaxone
- Replies: 1
- Views: 3744
New Study Rebif to Copaxone
Wednesday January 5 Serono's Rebif MS drug, Teva's Copaxone to go head-to-head in test ZURICH (AFX) - Serono SA said it has completed patient enrollment for its planned head-to-head comparative trial of its Rebif drug with Teva Pharmaceutical Industries Ltd's Copaxone in the treatment of relapsing r...
- Sun Jan 02, 2005 9:53 am
- Forum: Tysabri (Antegren, Natalizumab)
- Topic: Tysabri Webcast
- Replies: 62
- Views: 22248
01/03/05 Barron's Article
01/03/05 Barron's Article excerpt Up and Down Wall Street by Alan Abelson: But the company does have a half interest in Tysabri and, by Larry Feinberg's reckoning, that's pure gold. He figures there are roughly 800,000 MS patients in the U.S. and Europe. Of these, 330,000-350,000 are on drug therapy...
- Thu Dec 30, 2004 3:50 am
- Forum: Tysabri (Antegren, Natalizumab)
- Topic: Tysabri Webcast
- Replies: 62
- Views: 22248
Questions & Answers About Tysabri
Questions And Answers About Tysabri (Natalizumab) Q. What is Tysabri (pronounced tie-SAB-bree)? A. Tysabri (whose scientific name is natalizumab, pronounced: nat-tal-IZ-zue-mab) is a laboratory-produced monoclonal antibody. It was formerly called Antegren. It has been recently approved for marketing...
- Thu Dec 23, 2004 9:06 am
- Forum: General Discussion
- Topic: New Study Tysabri to Rebif
- Replies: 12
- Views: 4743
Head to head study
From Boston Herald.com Trial puts MS drugs head to head: Cambridge co. is favored by some Thursday, December 23, 2004 Biogen Idec Inc. has set up what amounts to a clinical trial smackdown with archrival Serono Inc., testing the safety and efficacy of the Cambridge firm's new multiple sclerosis trea...
- Wed Dec 22, 2004 9:47 am
- Forum: Tysabri (Antegren, Natalizumab)
- Topic: Tysabri Webcast
- Replies: 62
- Views: 22248
- Wed Dec 22, 2004 8:56 am
- Forum: Tysabri (Antegren, Natalizumab)
- Topic: Tysabri Webcast
- Replies: 62
- Views: 22248
S.G. Cowen notes Dec 22 04
These are some of the comments of the MS physicians surveyed concerning the impact of Tysabri On Existing Therapies "Physician 1: I think Rebif will be most negatively impacted by Tysabri because the only advantage it has is that is more potent than Avonex, and I think Tysabri would be a better...
- Tue Dec 21, 2004 6:06 am
- Forum: General Discussion
- Topic: New Study Tysabri to Rebif
- Replies: 12
- Views: 4743
New Study Tysabri to Rebif
21 December 2004 Biogen Idec and Elan Announce Head-to-Head Study Comparing Safety and Efficacy of TYSABRI® to Rebif® Zug, Switzerland – December 21, 2004 – Biogen Idec and Elan announced today that they are initiating a head-to-head study comparing the safety and efficacy of TYSABRI® (natalizumab) ...
- Mon Dec 20, 2004 4:30 am
- Forum: Tysabri (Antegren, Natalizumab)
- Topic: Earlier Natalizumab Trial
- Replies: 57
- Views: 16820